Matthew Richins, DPM
Foot Surgery · Joplin, MONPI 1003874181
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Organogenesis Inc. accounts for 74.1% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $84 and has fallen 52.3% since, to $40 in 2025. That places this record below the midpoint for foot surgery clinicians in MO, where the typical reported total is $1,075.
Across 11 payments — averaging $18.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$152
- Johnson & Johnson$36
- Amgen$17
What the payments were for
- Food & beverage$205100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 8 | $152 |
| Johnson & Johnson(2 entities) | 2 | $36 |
| Amgen | 1 | $17 |
How this compares
$205 in reported general payments places this provider in the 25th percentile of 21 foot surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 17 | $142 |
| Cephalexin | 15 | $72 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Joplin
- Jody McAleerJefferson City$3.6M
- Akilis TheoharidisGladstone$100K
- Mark SeidenSpringfield$20K
- Stephen PalmerKansas City$10K
- Robert BondiLees Summit$10K
- Laurel BondiLees Summit$5K
- Ronald LoucksFestus$4K
- Thomas HewittGladstone$2K
- Joel FosterLee's Summit$2K
- Anthony SikoutrisSedalia$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.